Cargando…
Déjà vu with a twist: transglutaminases in bioenergetics and transcriptional dysfunction in Huntington's disease
The article by McConoughey et al in the current issue of EMBO Molecular Medicine examines the contribution of transglutaminase 2 (TG2) to Huntington's disease (HD) pathogenesis. The authors find that TG2 inhibition can ameliorate HD neurodegeneration, and thereby elevate the status of transglut...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
WILEY-VCH Verlag
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377338/ https://www.ncbi.nlm.nih.gov/pubmed/20730854 http://dx.doi.org/10.1002/emmm.201000092 |